Nephrol Dial Transplant (2001) 16: 1653-1656
© 2001 European Renal Association-European Dialysis and Transplant Association
Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients
Steno Diabetes Center, Gentofte, Denmark
Background. An XbaI polymorphism in the gene encoding the glucose transporter, GLUT-1, is associated with development of diabetic nephropathy in Chinese type 2 diabetic patients. In addition, an amino acid variant (K121Q) in the gene encoding the glycoprotein plasma cell differentiating antigen (PC-1), a specific inhibitor of insulin receptor signalling, has been reported to predict a faster progression of nephropathy in Italian and British type 1 diabetic patients.
Methods. The XbaI and K121Q polymorphisms were determined by PCR-RFLP in Danish type 1 diabetic patients with nephropathy (122 men/77 women, age 40.9±9.6 years, diabetes duration 27±8 years) and type 1 diabetic patients with persistent normoalbuminuria (118 men/74 women, age 42.7±10.2 years, diabetes duration 26±9 years). Proliferative retinopathy was present in 156 patients (40%), while 67 patients (17%) had no diabetic retinopathy.
Results. There were no differences in the frequency of GLUT-1 XbaI genotypes between type 1 diabetic patients with diabetic nephropathy and type 1 diabetic patients with normoalbuminuria: 72 (41%)/87 (50%)/16 (9%) vs 94 (49%)/74 (39%)/24 (13%) had GLUT-1 XbaI +/+, +/- or -/- genotype respectively (NS). The frequency of PC-1 KK, KQ and QQ genotypes were 141 (71%)/52 (26%)/6 (3%) vs 138 (73%)/45 (24%)/7 (4%) in patients respectively with and without nephropathy (NS). Neither were associations between the investigated polymorphisms and simplex or proliferative retinopathy revealed.
Conclusions. Neither the PC-1 K121Q nor the GLUT-1 XbaI polymorphism contribute to the genetic susceptibility of diabetic microvascular complications in Danish type 1 diabetic patients.
Keywords: albuminuria; diabetic nephropathy; diabetic microangiopathy; GLUT-1 gene; PC-1 gene; type 1 diabetes
Correspondence and offprint requests to: Lise Tarnow, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. S. Roy, D. M. Hallman, Y.-P. Fu, M. Machado, and C. L. Hanis Assessment of 193 Candidate Genes for Retinopathy in African Americans With Type 1 Diabetes Arch Ophthalmol, May 1, 2009; 127(5): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Granier, K. Makni, L. Molina, B. Jardin-Watelet, H. Ayadi, and F. Jarraya Gene and protein markers of diabetic nephropathy Nephrol. Dial. Transplant., March 1, 2008; 23(3): 792 - 799. [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. De Cosmo, R. Trevisan, M. Dalla Vestra, M. Vedovato, A. Argiolas, A. Solini, A. Saller, F. Damone, A. Tiengo, V. Trischitta, et al. PC-1 Amino Acid Variant Q121 Is Associated With a Lower Glomerular Filtration Rate in Type 2 Diabetic Patients With Abnormal Albumin Excretion Rates Diabetes Care, October 1, 2003; 26(10): 2898 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Mogensen Genetics and Diabetic Renal Disease: Still a big black hole Diabetes Care, May 1, 2003; 26(5): 1631 - 1632. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Cosmo, G. Miscio, L. Zucaro, M. Margaglione, A. Argiolas, S. Thomas, G. Piras, R. Trevisan, P. C. Perin, S. Bacci, et al. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1402 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jacobsen, N. Grarup, L. Tarnow, H.-H. Parving, and O. Pedersen PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1408 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P.K. Ng, L. Canani, S.-i. Araki, A. Smiles, D. Moczulski, J. H. Warram, and A. S. Krolewski Minor Effect of GLUT1 Polymorphisms on Susceptibility to Diabetic Nephropathy in Type 1 Diabetes Diabetes, July 1, 2002; 51(7): 2264 - 2269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Canani, D. P.K. Ng, A. Smiles, J. J. Rogus, J. H. Warram, and A. S. Krolewski Polymorphism in Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 Gene (ENPP1/PC-1) and Early Development of Advanced Diabetic Nephropathy in Type 1 Diabetes Diabetes, April 1, 2002; 51(4): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|